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Abstract
Background: Escherichia coli is a rare cause of community-acquired meningitis in adults unless predisposing
factors are present (e.g., previous penetrating cranio-cerebral injury or neurosurgery, immunosuppression, chronic
alcoholism, history of cancer, diabetes mellitus, advanced age).
Case presentation: We describe the case of a 53-year-old woman, resident in Germany, suffering from community-
acquired bacterial meningitis caused by CTX-M-9 type extended spectrum β-lactamase producing Escherichia coli.
Because typical predisposing factors were not apparent, pathogen identification resulted in expanded diagnostics to
exclude a distant or contiguous primary focus. By magnetic resonance tomography, a previously unrecognized large
retropharyngeal abscess with cervical spondylodiscitis was detected. In retrospect, the patient had complained about
neck pain for a few weeks prior to meningitis onset, but the symptoms were interpreted as being related to a
herniated disk. Meningitis and osteomyelitis resolved completely under surgical treatment and meropenem therapy.
Conclusion: In case of adult Escherichia coli meningitis, underlying diseases should always be carefully excluded,
especially if predisposing factors are not apparent.
Keywords: community-acquired adult meningitis, Escherichia coli, Gram-negative bacillary meningitis, retropharyngeal
abscess, cervical spondylodiscitis, CTX-M-9 group ESBL, ST73
Background
Bacterial meningitis is a potentially life-threatening
neurological emergency requiring early recognition of
meningitis symptoms, rapid diagnostic evaluation of eti-
ology, and immediate antimicrobial therapy. Its esti-
mated annual incidence is 2–5 per 100,000 people in the
Western world, and it ranks among the top ten causes
of infection-related deaths worldwide and leads to per-
manent neurological sequelae in 30–50 % of the survi-
vors [1]. In immunocompetent children and adults,
meningitis is most often caused by Streptococcus pneu-
moniae and Neisseria meningitidis comprising over 80 %
of meningitis cases, followed by Streptococcus agalac-
tiae, Haemophilus influenzae and Listeria monocyto-
genes [2, 3]. In contrast, Escherichia coli is a rare
cause of community-acquired adult meningitis com-
prising about 1 % of meningitis cases [3–5] even
though it is a common pathogen in neonatal meningi-
tis [6] and in the nosocomial setting, especially after
penetrating cranio-cerebral injury or subsequent to
neurosurgical procedures [7]. Community-acquired
cases, however, occur almost exclusively in case of a
preexisting risk factor, such as advanced age, history
of cancer, immunosuppressive therapy, human im-
munodeficiency virus (HIV) infection, chronic alco-
holism, or diabetes mellitus, and typically secondary
to a distant or contiguous focus of infection, such as
urinary tract infection, gastrointestinal infection, or
otitis media [4, 5, 8–11]. Furthermore, the mortality
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rate is higher among patients with Escherichia coli
meningitis than among those with other bacterial
meningitides [4, 8].
We describe a community-acquired Escherichia coli
adult meningitis case caused by a CTX-M-9 type ex-
tended spectrum β-lactamase (ESBL) producing strain.
This case is of special interest because typical predispos-
ing factors for Escherichia coli meningitis were not ap-
parent. Thus, as a result of the unexpected pathogen
identification, expanded diagnostics was performed to
exclude a primary focus which led to diagnosis of previ-
ously unrecognized retropharyngeal abscess and cervical
spondylodiscitis.
Case presentation
A 53-year-old woman, resident in Germany, was admit-
ted to the emergency department because of confusion,
aphasia and agitation. Her partner reported that she had
complained about neck pain for a few weeks which had
been interpreted as being related to a herniated cervical
disk in an X-ray examination seven days ago and treated
with analgesics. Furthermore, the patient had suffered
from unspecific flu-like symptoms in the previous week
and intermittent diarrhea during the previous two
months. Her past medical history revealed a chronic ob-
structive pulmonary disease based on nicotine addiction,
a chronic pain syndrome following repeated vertebral
disk herniation, obesity, and appendectomy as well as
surgical repair of an epigastric and umbilical hernia six
years ago. Because of the chronic lumbar pain, she had
been under long-term morphine treatment with suspi-
cion of morphine addiction, but had not received
intraspinal steroid/analgesics injections for several
months.
On physical examination, she had a body temperature
of 38.6 °C; pulse rate and blood pressure were within the
normal range. In the examination of respiratory system,
cardiovascular system, and abdomen, no abnormalities
were detected. The neurological examination also
showed no abnormalities, especially no meningism and
no neurological deficits, apart from the confusion, apha-
sia and agitation. Laboratory analysis at admission
(Table 1) revealed a pronounced leukocytosis with an in-
crease mainly in the neutrophil granulocytes, and a
strongly elevated serum C-reactive protein level, indicat-
ing an infectious cause of the patient’s symptoms. Fur-
thermore, a rise of lactate dehydrogenase, liver enzymes
and cholestasis parameters, and a hyponatremia were
observed. In the emergency department, a magnetic res-
onance tomography of the brain was performed, but
demonstrated no abnormalities apart from first signs of
a subcortical arteriosclerotic encephalopathy.
An immediate lumbar puncture was not successful be-
cause of the patient’s agitation, but was conducted on
the second day of admission, when nuchal rigidity
emerged. Because of strongly suspected bacterial menin-
gitis, antimicrobial treatment with ceftriaxone (4 g daily
in two divided doses) and ampicillin (12 g daily in six di-
vided doses) was started. Analysis of the cerebrospinal
fluid (Table 1) was consistent with bacterial meningitis,
showing 1,657 leukocytes per μl, increased protein, un-
detectable glucose and increased lactate. Cerebrospinal
fluid was also subjected to microscopic Gram stain
examination and routine culture: The Gram stain re-
vealed a high number of Gram-negative rods, and
Escherichia coli grew on the culture plates. Species iden-
tification was performed by Matrix-Assisted Laser De-
sorption / Ionization (MALDI) Time of Flight (TOF)
Mass Spectrometry (Bruker Daltonics, Bremen,
Germany), and antimicrobial susceptibility testing was
done by microdilution in accordance with European
Committee on Antimicrobial Susceptibility Testing
(EUCAST) recommendations [12], using pre-configured
microtiter plates (MERLIN Diagnostika GmbH,
Bornheim-Hersel, Germany). The Escherichia coli strain
exhibited elevated minimum inhibitory concentrations
(MICs) for aminopenicillins (amoxicillin: >128 mg/l,
amoxicillin/clavulanic acid: 128/2 mg/l), oxyimino-
cephalosporins (cefotaxime: 16 mg/l, ceftazidime: 2 mg/
l), fourth-generation cephalosporins (cefepime: 64 mg/l)
and monobactams (aztreonam: 16 mg/l), a synergy
phenomenon in the double-disk synergy test with
amoxicillin/clavulanic acid consistent with an ESBL, and
a positive polymerase chain reaction (PCR) for blaCTX-
M-9 group. In contrast, it showed low MICs to piperacillin/
tazobactam (≤1/4 mg/l), carbapenems (imipenem:
0.0625 mg/l, meropenem: ≤0.03125 mg/l, ertapenem:
≤0.0625 mg/l, doripenem: ≤0.03125 mg/l) and fluoro-
quinolones (ciprofloxacin: ≤0.015625 mg/l, levofloxacin:
≤0.0625 mg/l), and was also susceptible to several other
types of antibiotics such as aminoglycosides, trimetho-
prim/sulfamethoxazole, tigecycline, colistin and fosfo-
mycin. In multilocus sequence typing (MLST), the
strain was assigned to ST73. On the second day after
admission, the initially taken blood cultures also flagged
positive for ESBL-producing Escherichia coli. Of note,
the patient’s ESBL carriage was not previously known.
The antimicrobial therapy was switched to meropenem
(6 g daily in three divided doses).
After pathogen identification, additional diagnostics
was performed to exclude a primary focus of infec-
tion: Although a urine culture yielded an Escherichia
coli strain having the same antimicrobial susceptibility
pattern, the patient’s past medical history was nega-
tive for urinary tract infection symptoms. Further-
more, chest X-ray, abdominal ultrasound and
transesophageal echocardiography conducted at ad-
mission and / or during the further hospital stay
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merely showed degenerative changes in the spine and
an early-stage atherosclerosis, but did not reveal a
primary focus. Thus, a magnetic resonance tomog-
raphy of the spine was added in consideration of the
patient’s neck pain even though that pain had already
been attributed to a herniated cervical disk. However,
magnetic resonance tomography showed a large de-
scending retropharyngeal abscess with a cervical
spondylodiscitis at C2-C3 down to C4-C5 and a sec-
ondary spinal canal stenosis (Fig. 1). Additionally,
multiple disk protrusions were found, especially in
the lumbar spine. Thus, the search for a source of
meningitis, initiated because of the unexpected patho-
gen identification, led to diagnosis of previously
unrecognized retropharyngeal abscess and cervical
spondylodiscitis. In addition to continued meropenem
treatment, the patient was immediately subjected to
neurosurgery: The abscess was evacuated including
polymethylmethacrylate-assisted ventral diskectomy.
Intraoperative swabs also yielded the ESBL-producing
Escherichia coli.
Initially, therapy was complicated by morphine with-
drawal delirium requiring sedation of the patient. Then,
the patient’s condition rapidly improved, and she had
fully recovered without any neurological sequelae when
meropenem treatment was stopped after 21 days (14
days after source-control surgery). Control computer
tomography and magnetic resonance tomography three
weeks and two months after admission, respectively,
both proved complete remission of the retropharyngeal
abscess and the spondylodiscitis. Nevertheless,
hospitalization was prolonged because of secondary
complications including prolonged dysphagia subsequent
to the retropharyngeal abscess and several hospital-
acquired infections. Specifically, the patient required
mechanical ventilation in the course of two hospital-
acquired pneumonia episodes, the first episode empiric-
ally treated with 7 days ceftriaxone and erythromycin,
the second with 7 days imipenem. Then, she received 7
days vancomycin for treatment of Enterococcus faecium
bacteremia. In addition, she developed bilateral trochan-
teric decubitus ulcers due to being bedridden for weeks.
ESBL-producing Escherichia coli was isolated from those
decubitus which were subsequently treated surgically
and with 10 days ciprofloxacin. Finally, the patient re-
ceived 12 days caspofungin because of candidemia. Of
the antimicrobials used for therapy of the hospital-
acquired infections, imipenem and ciprofloxacin also
had in vitro activity against the meningitis-causing
Escherichia coli strain. However, neither clinical nor
radiological signs of a meningitis relapse occurred after
cessation of meropenem, which may indicate that the
meningitis had already been cured at the time-point of
meropenem cessation. After all, the patient was dis-
charged from hospital in good health three months after
admission.
Discussion
Previous case series on adult Gram-negative bacillary
meningitis usually include or even focus on nosoco-
mial meningitis cases which occur particularly subse-
quent to penetrating cranio-cerebral injury or
neurosurgery [4, 5, 8–11, 13, 14], whereas Escherichia
coli is a rare cause of community-acquired adult men-
ingitis [3–5]. However, in the present case there was
no evidence of a nosocomial meningitis origin. In
particular, the patient had never received any intrasp-
inal injections close to the cervical spine and an infil-
tration of the lumbar spine dated back several
months. Considering only the community-acquired
adult Gram-negative bacillary meningitis cases
Table 1 Selected results of laboratory testing at admission and





Blood leucocytes (10^3/μl) 4.0–9.0 33.5
Blood neutrophil granulocytes (%) 50–70 90, with a left shift
Blood lymphocytes (%) 25–40 3
Blood monocytes (%) 2–14 5
Blood erythrocytes (10^6/μl) 4.0–5.5 5.1
Blood thrombocytes (10^3/μl) 150–400 292
Serum C-reactive protein (mg/l) 0.0–5.0 163.9
Serum procalcitonin (ng/ml) 0.05–0.24 0.29
Serum creatine kinase (U/l) 0–190 63
Serum lactate dehydrogenase (U/l) 0–249 423
Serum alanine transaminase (U/l) 12–78 156
Serum aspartate transaminase (U/l) 0–35 38
Serum gamma-glutamyltransferase (U/l) 0–55 160
Serum total bilirubin (mg/dl) 0.0–1.0 1.84
Serum lipase (U/l) 73–393 303
Serum total protein (g/dl) 6.6–8.7 7.0
Blood glucose (mg/dl) 60–120 95
Serum creatinine (mg/dl) 0.5–1.1 0.7
Serum sodium (mval/l) 136–145 129
Serum potassium (mval/l) 3.5–5.1 4.3
Liquor leucocytes (/μl) 0–5 1,657
Liquor neutrophil granulocytes (%) 0–4 53.1
Liquor lymphocytes (%) 48–72 3.9
Liquor monocytes (%) 15–45 41.8
Liquor protein (mg/dl) 15–35 204.5
Liquor glucose (mg/dl) 25–60 0
Liquor lactate (mmol/l) 0.6–2.2 13.2
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included in the above mentioned case series, it is
striking that most cases, namely about 75 % [4, 8] to
95 % [5, 9], occurred in patients with predisposing
risk factors such as advanced age, history of cancer,
immunosuppressive therapy, HIV infection, chronic
alcoholism, or diabetes mellitus. However, our patient
did not display any of those risk factors. Moreover,
about 75 % of the cases [4, 8] occurred secondary to
a distant or contiguous infection (e.g., urinary tract
infection, gastrointestinal infection, or otitis media).
Thus, in the present case, diagnostics was extended
after pathogen identification to exclude a primary
focus of infection, which led to diagnosis of the previ-
ously unrecognized retropharyngeal abscess with cer-
vical spondylodiscitis. Consequently, our case report
highlights the importance of searching for a source of
meningitis in cases of Escherichia coli adult meningi-
tis, especially if typical risk factors are not apparent.
Probably, the patient’s meningitis as well as the cer-
vical spondylodiscitis had arisen through contiguous
spread from the retropharyngeal abscess. However, ret-
ropharyngeal abscesses are mainly polymicrobial infec-
tions containing common oropharyngeal microflora but
not Enterobacteriaceae. Typically, they are caused by an-
aerobic organisms and beta-hemolytic streptococci (es-
pecially Streptococcus pyogenes), followed by viridans
group streptococci, Staphylococcus aureus, Haemophilus
influenzae and Streptococcus pneumoniae [15, 16]. Fur-
thermore, the majority of spondylodiscitis cases are
acquired by hematogenous spread, followed by direct ex-
ternal inoculation, whereas spread from contiguous tis-
sues is comparably rare [17]. In hematogenous
spondylodiscitis, Staphylococcus aureus is most com-
monly identified (apart from tuberculosis which is the
leading cause worldwide), but multiple other pathogens
may also be causative agents. In case of direct external
inoculation, cutaneous organisms may also be found.
Thus, even though Escherichia coli may be no rarity in
hematogenous spondylodiscitis, in cases acquired
through contiguous spread based on a retropharyngeal
abscess one would expect pathogens from the oropha-
ryngeal microflora rather than Escherichia coli.
Because Escherichia coli is no typical cause of a retro-
pharyngeal abscess, one may suppose a previous
unrecognized Escherichia coli bacteremia. However, a
precedent distant focus of infection was not found in the
present case and, therefore, the reason for the retrophar-
yngeal abscess remains elusive. In particular, the patient’s
past medical history was negative for urinary tract infec-
tion symptoms even though one urine culture yielded
the ESBL-producing Escherichia coli strain. The latter
may be explained by colonization of the urinary tract
subsequent to an assumable colonization of the gastro-
intestinal tract, or, less likely, may result from the
bacteremia present during the meningitis episode. The
hypothesis of lasting gastrointestinal and urinary tract
colonization is supported by the fact that the ESBL-
producing Escherichia coli strain was detected from the
patient’s bilateral trochanteric decubitus ulcers which
occurred only after full meningitis remission and were,
thus, probably not related to the meningitis episode. In
addition, normal findings in abdominal ultrasound argue
against a precedent gastrointestinal infection although
the patient reported that she had had intermittent diar-
rhea during the previous two months. The abnormal
liver function test results may, in consideration of previ-
ously normal values, also be interpreted as accompany-
ing sepsis-related changes because hepatic dysfunction
represents a common manifestation during sepsis
process [18]. Furthermore, prior abdominal surgery as a
potential source of Escherichia coli bacteremia dated
back several years.
Of note, the presented community-acquired Escheri-
chia coli adult meningitis was caused by an ESBL-
producing strain. This may increase the significance of
the present case report because ESBL-producing strains
have been rarely identified in Escherichia coli meningitis,
in community-acquired cases even less than in the noso-
comial setting [13, 19, 20]. Our Escherichia coli isolate
produced a CTX-M-9 group ESBL and was assigned to
ST73 in MLST. To the best of our knowledge, this is the
first report of a CTX-M-9 group ESBL in the setting of
Escherichia coli meningitis. CTX-M-9 group ESBLs are
Fig. 1 Result of magnetic resonance tomography of neck and
spine. Magnetic resonance tomography, done on the seventh
day after admission, showed the descending retropharyngeal
abscess, measuring 7 cm × 3.5 cm × 1.5 cm, and the cervical
spondylodiscitis at C2-C3 down to C4-C5
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comparably infrequent in Germany, accounting for only
7–12 % of ESBLs detected in Escherichia coli isolates
(for comparison: CTX-M-1-group 80–93 %) [21, 22]. In
contrast, ST73, along with ST131, ST69, and ST95, be-
longs to the major pandemic clonal lineages as was sum-
marized in a recent review [23]. Interestingly, in some of
the reviewed studies providing appropriate subanalyses,
ST73 strains tended to occur more frequently in
community-acquired than in hospital-acquired infections
[24, 25], but were only rarely (0–2 %) associated with
ESBL production [24, 26].
Conclusion
Community-acquired Escherichia coli adult meningitis is
a rare entity which usually occurs merely in case of pre-
disposing factors. If typical risk factors are not apparent,
it may be prudent to extend diagnostics for exclusion of
underlying diseases and precedent infections.
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